Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target

被引：0
|
作者：
Dongli Liu
Kate Gunther
Luis A. Enriquez
Benjamin Daniels
Tracy A. O’Mara
Katrina Tang
Amanda B. Spurdle
Caroline E. Ford
机构：
[1] University of New South Wales,Gynaecological Cancer Research Group, Lowy Cancer Research Centre, School of Women’s and Children’s Health, Faculty of Medicine
[2] University of New South Wales,Medicines Policy Research Unit, Centre for Big Data Research in Health, Faculty of Medicine
[3] QIMR Berghofer Medical Research Institute,South Eastern Area Laboratory Services Pathology
[4] Prince of Wales Hospital,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] ROR1 and ROR2-novel targets for neuroblastoma
    Dave, Hema
    Butcher, Donna
    Anver, Miriam
    Bollard, Catherine M.
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (06) : 352 - 364
  • [12] The role of Ror1 receptor in cancer
    Lopez Bergami, Pablo
    [J]. ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2011, 45 (04): : 665 - 668
  • [13] ROR1 and ROR2 expression in pancreatic cancer
    Dongli Liu
    George Sharbeen
    Phoebe Phillips
    Caroline E. Ford
    [J]. BMC Cancer, 21
  • [14] Correction: Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
    Junjian Wang
    June X Zou
    Xiaoqian Xue
    Demin Cai
    Yan Zhang
    Zhijian Duan
    Qiuping Xiang
    Joy C Yang
    Maggie C Louie
    Alexander D Borowsky
    Allen C Gao
    Christopher P Evans
    Kit S Lam
    Jianzhen Xu
    Hsing-Jien Kung
    Ronald M Evans
    Yong Xu
    Hong-Wu Chen
    [J]. Nature Medicine, 2016, 22 : 692 - 692
  • [15] Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
    C. E. Henry
    E. Llamosas
    A. Djordjevic
    N. F. Hacker
    C. E. Ford
    [J]. Oncogenesis, 11
  • [16] ROR1 and ROR2 expression in pancreatic cancer
    Liu, Dongli
    Sharbeen, George
    Phillips, Phoebe
    Ford, Caroline E.
    [J]. BMC CANCER, 2021, 21 (01)
  • [17] ROR1 as a Therapeutic Target In E2A-PBX1-Positive Acute Lymphoblastic Leukemia
    Bicocca, Vincent
    Chang, Bill H.
    Muschen, Markus
    Druker, Brian J.
    Tyner, Jeffrey W.
    [J]. BLOOD, 2010, 116 (21) : 240 - 240
  • [18] Novel humanized monoclonal antibodies against ROR1 for cancer therapy
    Wei, Rong
    Liao, Xun
    Li, Jiao
    Mu, Xiaoyu
    Ming, Yue
    Peng, Yong
    [J]. MOLECULAR CANCER, 2024, 23 (01)
  • [19] Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
    Juho Heliste
    Anne Jokilammi
    Ilkka Paatero
    Deepankar Chakroborty
    Christoffer Stark
    Timo Savunen
    Maria Laaksonen
    Klaus Elenius
    [J]. BMC Cardiovascular Disorders, 18
  • [20] ROR1 amplification and overexpression in ovarian cancer
    Miller, Carl
    Walsh, Christine
    Xu, Xuan
    Lu, Quingjie
    Ong, Katy
    Karlan, Beth
    Orsulic, Sandra
    [J]. CANCER RESEARCH, 2009, 69
12345